Search For "novavax"
Novovax' COVID-19 vaccine gets emergency use authorisation for adolescents
Updated : 4 years, 2 months ago IST
New Delhi [India], March 23 (ANI): Novavax on Tuesday announced the first emergency use authorization of its COVID-19 vaccine for adolescents falling in the age bracket of 12-18 years in India.
Read More
Novavax, Serum Institute file for emergency use authorisation of Novavax'
Updated : 4 years, 4 months ago IST
Gaithersburg [US], January 10 (ANI): Novavax, a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India (SII), on Monday, announced a regulatory submission to the South African Health Products Re
Read More
SK Bioscience to purchase 5 million doses of additional vaccines from Nova
Updated : 4 years, 4 months ago IST
Seoul [South Korea], January 3 (ANI/Global Economic): SK Bioscience signed a contract to pre-purchase up to 5 million doses of Novavax's COVID-19 vaccine 'NVX-CoV2373' in 2022.
Read More
Covovax authorisation is a vital step in India, where additional vaccine o
Updated : 4 years, 4 months ago IST
Gaithersburg/Pune (Maryland/Maharashtra)[US/India], December 29 (ANI): Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India (SII), the world's largest vaccin
Read More
Centre clears two new COVID vaccines, one antiviral drug; manufacturers we
Updated : 4 years, 4 months ago IST
New Delhi [India], December 28 (ANI): After the Union Health Ministry cleared two new COVID-19 vaccines and one anti-viral drug for emergency use on Tuesday, vaccine manufacturers welcomed the announcement and said that this would support the patients across India.
Read More
WHO approves emergency use of COVID-19 vaccine Covovax
Updated : 4 years, 5 months ago IST
Geneva [Switzerland], December 17 (ANI): The World Health Organization (WHO) said it had approved the Covovax coronavirus vaccine, which is manufactured by the Serum Institute of India under license from US company Novavax, for emergency use.
Read More
Novavax begins early-stage trial for combined influenza, COVID-19 vaccines
Updated : 4 years, 8 months ago IST
Washington [US], September 8 (ANI): US firm Novavax on Wednesday announced that it has initiated an early stage to evaluate the safety and immunogenicity of a combined flu Novavax' seasonal influenza and COVID-19 vaccines.
Read More
COVID-19 vaccine manufacturing firms being encouraged to conduct paediatri
Updated : 4 years, 9 months ago IST
New Delhi [India], July 27 (ANI): After trials on adults, COVID-19 vaccine manufacturing companies Biological E and Novavax are being encouraged to conduct a study on paediatrics, said Member-Health of NITI Aayog Dr VK Paul on Tuesday.
Read More
Novavax's COVID-19 vaccine 'Covavax' to launch in India by September: Sour
Updated : 4 years, 11 months ago IST
New Delhi [India], June 17 (ANI): The Serum Institute of India (SII) hopes to introduce US firm Novavax's Indian version of the COVID-19 vaccine - 'Covavax' by September this year and start trials on children from July.
Read More
Novavax results are promising, hope company starts trial on children soon:
Updated : 4 years, 11 months ago IST
New Delhi [India], June 15 (ANI): The Centre on Tuesday said clinical trials of the Novavax COVID-19 vaccine in India are in an advanced stage of completion and hoped the US-based company will soon start trials of its protein-based vaccine on children too.
Read More
Novavax's vaccine, also produced by SII, found 90 pc effective against COV
Updated : 4 years, 11 months ago IST
New Delhi [India], June 14 (ANI): US Biotechnology company Novavax on Monday announced that its Covid-19 vaccine provides 100 per cent protection against moderate and severe symptoms of the disease and 90.4 per cent efficacy overall in phase 3 trials.
Read More
US to lift Defense Production Act ratings on AstraZeneca, Novavax, Sanofi
Updated : 4 years, 11 months ago IST
Washington [US], June 4 (ANI): White House COVID-19 response coordinator Jeff Zients said on Thursday that the US will lift Defense Production Act ratings on the AstraZeneca, Novavax, and Sanofi COVID vaccines.
Read More